Is Oclaro, Inc. (OCLR) Going to Burn These Hedge Funds?

Page 1 of 2

Is Oclaro, Inc. (NASDAQ:OCLR) undervalued? Money managers are turning less bullish. The number of bullish hedge fund positions were trimmed by 2 lately.

At the moment, there are a multitude of methods shareholders can use to analyze their holdings. A couple of the most under-the-radar are hedge fund and insider trading sentiment. At Insider Monkey, our research analyses have shown that, historically, those who follow the top picks of the top investment managers can trounce their index-focused peers by a superb amount (see just how much).

Equally as key, bullish insider trading sentiment is a second way to parse down the stock market universe. There are plenty of incentives for a bullish insider to sell shares of his or her company, but just one, very simple reason why they would initiate a purchase. Many academic studies have demonstrated the valuable potential of this tactic if “monkeys” understand where to look (learn more here).

Consequently, we’re going to take a glance at the recent action regarding Oclaro, Inc. (NASDAQ:OCLR).

Hedge fund activity in Oclaro, Inc. (NASDAQ:OCLR)

In preparation for this year, a total of 6 of the hedge funds we track held long positions in this stock, a change of -25% from one quarter earlier. With the smart money’s positions undergoing their usual ebb and flow, there exists a select group of notable hedge fund managers who were increasing their holdings significantly.

Oclaro, Inc. (NASDAQ:OCLR)Of the funds we track, Chuck Royce’s Royce & Associates had the largest position in Oclaro, Inc. (NASDAQ:OCLR), worth close to $3.2 million, accounting for less than 0.1%% of its total 13F portfolio. Coming in second is Mark Broach of Manatuck Hill Partners, with a $1.6 million position; the fund has 0.2% of its 13F portfolio invested in the stock. Other peers that are bullish include Jim Simons’s Renaissance Technologies, Cliff Asness’s AQR Capital Management and Israel Englander’s Millennium Management.

Because Oclaro, Inc. (NASDAQ:OCLR) has faced falling interest from the entirety of the hedge funds we track, it’s easy to see that there is a sect of hedge funds who were dropping their entire stakes last quarter. At the top of the heap, John Kleinheinz’s Kleinheinz Capital Partners sold off the largest stake of the 450+ funds we key on, worth close to $9.1 million in stock., and Thomas E. Claugus of GMT Capital was right behind this move, as the fund sold off about $0.4 million worth. These transactions are intriguing to say the least, as aggregate hedge fund interest fell by 2 funds last quarter.

What do corporate executives and insiders think about Oclaro, Inc. (NASDAQ:OCLR)?

Insider purchases made by high-level executives is most useful when the primary stock in question has seen transactions within the past 180 days. Over the latest half-year time frame, Oclaro, Inc. (NASDAQ:OCLR) has seen zero unique insiders purchasing, and 2 insider sales (see the details of insider trades here).

Let’s also take a look at hedge fund and insider activity in other stocks similar to Oclaro, Inc. (NASDAQ:OCLR). These stocks are Mattson Technology, Inc. (NASDAQ:MTSN), eMagin Corporation (NYSEAMEX:EMAN), Mindspeed Technologies, Inc. (NASDAQ:MSPD), Axcelis Technologies Inc (NASDAQ:ACLS), and Cascade Microtech, Inc. (NASDAQ:CSCD). This group of stocks are the members of the semiconductor equipment & materials industry and their market caps match OCLR’s market cap.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

The Most Successful Reality TV Stars

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!